Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.
Moxonidine is prescribed for the treatment of hypertension and the approval strengthens Relonchem’s growing product presence ...
United Therapeutics Corporation ( NASDAQ: UTHR) Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 1:10 PM EDT ...
The IPO is aimed at strengthening Atlanta Electricals’ manufacturing base and providing liquidity to its promoter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback